(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-27 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 197270
| Date | Daily Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 1.87 | 2.00 | 2.00 | 1.85 | 0.926 times |
| 26 Wed Jun 2024 | 1.79 | 1.78 | 1.86 | 1.78 | 0.256 times |
| 25 Tue Jun 2024 | 1.78 | 1.84 | 1.90 | 1.78 | 0.491 times |
| 24 Mon Jun 2024 | 1.83 | 1.83 | 1.92 | 1.83 | 0.599 times |
| 21 Fri Jun 2024 | 1.78 | 1.92 | 1.95 | 1.78 | 2.605 times |
| 20 Thu Jun 2024 | 1.91 | 1.88 | 1.96 | 1.85 | 0.484 times |
| 18 Tue Jun 2024 | 1.87 | 1.89 | 1.99 | 1.87 | 0.579 times |
| 18 Tue Jun 2024 | 1.87 | 1.89 | 1.99 | 1.87 | 0.579 times |
| 17 Mon Jun 2024 | 1.93 | 2.04 | 2.04 | 1.80 | 2.906 times |
| 14 Fri Jun 2024 | 2.04 | 2.10 | 2.20 | 1.98 | 0.743 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.9, but if it comes above 1.9, then a intra day buy could be more profitable.
If you take a sell trade below 1.9, then use 1.9 as stoploss and 1.7 as target. However if you take a buy trade in stock , then use 1.9 as stoploss and 2 as target.
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.43 |
| Downside Target | 1.71 |
| Downside Target | 1.78 |
| Upside Target | 1.94 |
| Upside Target | 1.98 |
| Upside Target | 2.04 |
| Upside Target | 2.22 |
| Upside Target | 2.28 |
| Upside Target | 2.34 |
| Upside Target | 2.35 |
| Upside Target | 2.58 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 1.77 |
| Downside Intraday Target | 1.66 |
| Upside Intraday Target | 1.99 |
| Upside Intraday Target | 2.1 |
| Upside Intraday Target | 1.88 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 1.87 | 1.83 | 2.00 | 1.78 | 0.619 times |
| 21 Fri Jun 2024 | 1.78 | 1.89 | 1.99 | 1.78 | 1.053 times |
| 18 Tue Jun 2024 | 1.87 | 2.04 | 2.04 | 1.80 | 0.947 times |
| 14 Fri Jun 2024 | 2.04 | 2.02 | 2.22 | 1.98 | 1.114 times |
| 07 Fri Jun 2024 | 2.03 | 2.15 | 2.28 | 2.00 | 0.847 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 1.87 | 2.15 | 2.28 | 1.78 | 0.425 times |
| 31 Fri May 2024 | 2.16 | 1.53 | 2.35 | 1.43 | 2.406 times |
| 30 Tue Apr 2024 | 1.55 | 1.78 | 1.94 | 1.30 | 0.663 times |
| 28 Thu Mar 2024 | 1.78 | 2.25 | 2.34 | 1.71 | 1.061 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term and the sell signal is strong.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.87 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term and the sell signal is strong.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.87 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.